DRKS00005268已完成未知
A pharmacological provocation of the glutamatergic and the cholinergic system. A fMRI study. - NEWMDES pharmaco fmri
ZI Mannheim0 个研究点目标入组 24 人开始时间: 2013年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •healthy volunteers
排除标准
- •pregnany, psychiatric or neurologic disease, contraindications for scopolamine or ketamine, glaucoma, tachyarrhythmia, ileus, myasthenia gravis, hyperthyreosis, renal insufficiency, liver function disorder, history of heart disease
研究者
相似试验
进行中（未招募）
1 期
GOAT - Glutamatergic medication in the treatment of Obsessive Compulsive Disorder (OCD) and Autism Spectrum Disorder (ASD)Obsessive Compulsive Disorders (OCD) Autism Spectrum Disorders (ASD)MedDRA version: 19.1Level: PTClassification code 10063844Term: Autism spectrum disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 19.1Level: PTClassification code 10029898Term: Obsessive-compulsive disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2014-003080-38-GBRadboud University, Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour100
进行中（未招募）
不适用
The role of the glutamatergic system in the extinction of conditioned reinforcement processes - The role of the glutamatergic system in the extinction of conditioned reinforcement processesAlcohol-dependence is an important factor contributing to health care costs. Alcohol-dependent patients show conditioned reactions to stimuli that were associated with substance consumption and several studies demonstrated that these reactions are related to relapse after treatment. Based on recent research with phobic patients the aim of this clinical trial is to study whether the combination of extinction training with Cycloserine enhances treatment efficacy.MedDRA version: 9.1Level: LLTClassification code 10001594Term: Alcohol dependence syndromeEUCTR2006-007090-72-DECentral Institute of Mental Health
已完成
3 期
Glutamatergic medication in the treatment of Obsessive Compulsive Disorder (OCD) and Autism Spectrum Disorder (ASD)Obsessief Compulsieve StoornisAutism Spectrum Disorder and Obsessive Compulsive Disorder10010118NL-OMON41943Radboudumc, Donders Institute of Brain, Cognition and Behavior48
尚未招募
不适用
Monosodium glutamate as a potential trigger for atrial fibrillatioAFatrialfibrillation10007521NL-OMON34775Academisch Medisch Centrum25
已完成
不适用
The influence of symptom provocation on glutamate in obsessive-compulsive disorder - a functional magnetic resonance spectroscopy studyalcoholismObsessive-compulsive disorderNL-OMON49350Vrije Universiteit Medisch Centrum60